June was a challenging month for Novo Nordisk regarding cybersecurity and intellectual property protection. The pharma giant allegedly had some of its data — including intellectual property — stolen by two independent groups of threat actors. Unaware of each other, each group claimed to have acquired a large amount of valuable information. One demanded $25... Source